Evicenter
P&T meetings

Ulixacaltamide

Essential tremor

Regulatory submission
NDA submitted by February 2026
Launch
Not announced
Last updated
78 sources

Product information and disease descriptionProduct description

Product information

22 evidence topics · 24 sources

Contraindications/Warnings/Precautions/Adverse effects
Warnings and precautions

Not applicable.

Drug/Drug, drug/disease interactions
Effects of other drugs on Ulixacaltamide

No evidence found.

Effects of Ulixacaltamide on other drugs

No evidence found.

Effect of Ulixacaltamide on quality measures

No evidence found.